AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
STI
SunTrust Banks, Inc.
STI
|
+$301M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$258M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$255M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$236M |
| 5 |
Biogen
BIIB
|
+$232M |
Top Sells
| 1 |
Honeywell
HON
|
+$323M |
| 2 |
AET
Aetna Inc
AET
|
+$205M |
| 3 |
CVS Health
CVS
|
+$197M |
| 4 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$196M |
| 5 |
Apple
AAPL
|
+$193M |
Sector Composition
| 1 | Financials | 16.28% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.19% |
| 4 | Consumer Discretionary | 10.93% |
| 5 | Industrials | 10.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Cross Country Healthcare
CCRN
$457M
| $486K | ﹤0.01% |
38,095
| – | – |
|
|
WIN
2527
DELISTED
Windstream Holdings Inc
WIN
| $483K | ﹤0.01% |
52,237
-6,480
| -11% | -$59.9K |
|
2528
Sonic Automotive
SAH
$2.78B
| $482K | ﹤0.01% |
26,113
-5,200
| -17% | -$96K |
|
2529
Aclaris Therapeutics
ACRS
$222M
| $481K | ﹤0.01% |
19,500
| – | – |
|
2530
Celldex Therapeutics
CLDX
$1.67B
| $481K | ﹤0.01% |
11,287
-574
| -5% | -$24.5K |
|
2531
Forrester Research
FORR
$193M
| $480K | ﹤0.01% |
10,858
-1,800
| -14% | -$79.6K |
|
|
AMNB
2532
DELISTED
American National Bankshares Inc
AMNB
| $479K | ﹤0.01% |
12,500
-300
| -2% | -$11.5K |
|
|
EPZM
2533
DELISTED
Epizyme, Inc
EPZM
| $479K | ﹤0.01% |
38,200
-4,200
| -10% | -$52.7K |
|
2534
TFS Financial
TFSL
$3.76B
| $478K | ﹤0.01% |
32,016
+670
| +2% | +$10K |
|
|
CHFN
2535
DELISTED
Charter Financial Corp
CHFN
| $478K | ﹤0.01% |
27,276
-900
| -3% | -$15.8K |
|
2536
Patriot National Bancorp
PNBK
$139M
| $477K | ﹤0.01% |
26,720
+75
| +0.3% | +$1.34K |
|
|
PRTK
2537
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $476K | ﹤0.01% |
26,600
| – | – |
|
|
SGY
2538
DELISTED
Stone Energy
SGY
| $476K | ﹤0.01% |
14,800
+6,400
| +76% | +$206K |
|
|
TVRD
2539
Tvardi Therapeutics, Inc. Common Stock
TVRD
$305M
| $472K | ﹤0.01% |
1,072
| – | – |
|
2540
Wave Life Sciences
WVE
$1.17B
| $470K | ﹤0.01% |
13,400
+700
| +6% | +$24.6K |
|
2541
Abeona Therapeutics
ABEO
$347M
| $469K | ﹤0.01% |
+1,184
| New | +$469K |
|
|
INXN
2542
DELISTED
Interxion Holding N.V.
INXN
| $468K | ﹤0.01% |
7,934
| – | – |
|
|
ANCX
2543
DELISTED
Access National Corporation
ANCX
| $465K | ﹤0.01% |
16,687
+5,790
| +53% | +$161K |
|
2544
Petrobras Class A
PBR.A
$75B
| $463K | ﹤0.01% |
47,096
+5,280
| +13% | +$51.9K |
|
|
VRN
2545
DELISTED
Veren
VRN
| $463K | ﹤0.01% |
60,742
-2,550
| -4% | -$19.4K |
|
2546
Core Laboratories
CLB
$582M
| $460K | ﹤0.01% |
4,203
-583
| -12% | -$63.8K |
|
2547
Kforce
KFRC
$550M
| $460K | ﹤0.01% |
18,200
-5,500
| -23% | -$139K |
|
2548
Park Aerospace
PKE
$374M
| $459K | ﹤0.01% |
23,356
-1,900
| -8% | -$37.3K |
|
2549
Tredegar Corp
TG
$271M
| $453K | ﹤0.01% |
23,619
-1,900
| -7% | -$36.4K |
|
|
KLDX
2550
DELISTED
KLONDEX MINES LTD
KLDX
| $453K | ﹤0.01% |
173,600
-40,400
| -19% | -$105K |
|